| Literature DB >> 29444768 |
XingRong Shen1, Manman Lu1, Rui Feng2, Jing Cheng1, Jing Chai1, Maomao Xie1, Xuemeng Dong1, Tao Jiang1, Debin Wang1.
Abstract
BACKGROUND: Excessive use of antibiotics is very common worldwide, especially in rural China; various measures that have been used in curbing the problem have shown only marginal effects.Entities:
Keywords: China; drug resistance, bacterial; internet; primary health care; randomized controlled trial
Mesh:
Substances:
Year: 2018 PMID: 29444768 PMCID: PMC5830611 DOI: 10.2196/jmir.8922
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Flowchart of participant selection and follow-up.
Sociodemographic characteristics and symptomatic infections.
| Participant group | Baseline | Endpoint | Overall | |||||
| Control (n=263), n (%) | Intervention (n=269), n (%) | Control (n=254), n (%) | Intervention (n=262), n (%) | |||||
| .90 | .81 | .97 | ||||||
| ≤30 | 52 (19.8) | 53 (19.7) | 50 (19.7) | 54 (20.6) | ||||
| 31-40 | 51 (19.4) | 58 (21.6) | 49 (19.3) | 57 (21.8) | ||||
| 41-50 | 53 (20.2) | 59 (21.9) | 51 (20.1) | 55 (21.0) | ||||
| 51-60 | 52 (19.8) | 47 (17.5) | 49 (19.3) | 50 (19.1) | ||||
| ≥61 | 55 (20.8) | 52 (19.3) | 55 (21.6) | 46 (17.6) | ||||
| .65 | .42 | .63 | ||||||
| Male | 86 (32.7) | 83 (30.9) | 75 (29.5) | 86 (32.8) | ||||
| Female | 177(67.3) | 186 (69.1) | 179 (70.5) | 176 (67.2) | ||||
| .94 | .73 | .999 | ||||||
| Illiteracy | 63 (24.0) | 60 (22.3) | 67 (26.4) | 58 (22.1) | ||||
| Primary school | 72 (27.4) | 71 (26.4) | 61 (24.0) | 68 (26.0) | ||||
| Middle school | 85 (32.3) | 92 (34.2) | 85 (33.5) | 91 (34.7) | ||||
| High school | 43 (16.3) | 46 (17.1) | 41 (16.1) | 45(17.2) | ||||
| .81 | .70 | .37 | ||||||
| RTIsa | 200 (76.0) | 207 (77.0) | 207 (81.5) | 210 (80.2) | ||||
| GTIsb | 63 (24.0) | 62 (23.0) | 47 (18.5) | 52 (19.8) | ||||
aRTIs: respiratory tract infections.
bGTIs: gastrointestinal tract infections.
Practices of essential service procedures at baseline and endpoint.
| Procedure | Baseline | Endpoint | Overall | |||||
| Control, n (%) | Intervention, n (%) | Control, n (%) | Intervention, n (%) | |||||
| Yes | 52 (19.8) | 54 (20.1) | .93 | 52 (20.5) | 237 (90.5) | <.001 | <.001 | |
| No | 211 (80.2) | 215 (79.9) | 202 (79.5) | 25 (9.5) | ||||
| Yes | 65 (24.7) | 59 (21.9) | .45 | 63 (24.8) | 236 (90.1) | <.001 | <.001 | |
| No | 198 (75.3) | 210 (78.1) | 191 (75.2) | 26 (9.9) | ||||
| Yes | 62 (23.6) | 57 (21.2) | .51 | 61 (24.0) | 238 (90.8) | <.001 | <.001 | |
| No | 201 (76.4) | 212 (78.8) | 193 (76.0) | 24 (9.2) | ||||
| Yes | 36 (13.7) | 37 (13.8) | .98 | 40 (15.7) | 232 (88.5) | <.001 | <.001 | |
| No | 227 (86.3) | 232 (86.2) | 214 (84.3) | 30 (12.2) | ||||
| Yes | 28 (10.6) | 27 (10.0) | .82 | 30 (11.8) | 242 (92.4) | <.001 | <.001 | |
| No | 235 (89.4) | 242 (90.0) | 224 (88.2) | 20 (7.6) | ||||
| Yes | 17 (6.5) | 15 (5.6) | .67 | 17 (6.7) | 242 (92.4) | <.001 | <.001 | |
| No | 246 (93.5) | 254 (94.4) | 237 (93.3) | 20 (7.6) | ||||
| Yes | 12 (4.6) | 16 (5.9) | .47 | 17 (6.7) | 247 (94.3) | <.001 | <.001 | |
| No | 251 (95.4) | 253 (94.1) | 237 (93.3) | 15 (5.7) | ||||
| Yes | 32 (12.2) | 31 (11.5) | .82 | 32 (12.6) | 249 (95.0) | <.001 | <.001 | |
| No | 231 (87.8) | 238 (88.5) | 222 (87.4) | 13 (5.0) | ||||
| Yes | 8 (3.0) | 7 (2.6) | .76 | 7 (2.8) | 248 (94.7) | <.001 | <.001 | |
| No | 255 (97.0) | 262 (97.4) | 247 (97.2) | 14 (5.3) | ||||
| Yes | 9 (3.4) | 8 (3.0) | .77 | 8 (3.1) | 241 (92.0) | <.001 | <.001 | |
| No | 254 (96.6) | 261 (97.0) | 246 (96.9) | 21 (8.0) | ||||
aRTIs: respiratory tract infections.
bGTIs: gastrointestinal tract infections.
Changes in patients’ beliefs and knowledge about antibiotics and infections.
| Questionnaire item | Baseline | Endpoint | Overall | |||||
| Control, n (%) | Intervention, n (%) | Control, n (%) | Intervention, n (%) | |||||
| Yes or Not clear | 189 (71.9) | 192 (71.4) | .90 | 182 (71.7) | 156 (59.5) | .004 | .004 | |
| No | 74 (27.2) | 77 (28.6) | 72 (28.3) | 106 (40.5) | ||||
| Yes or Not clear | 223 (84.8) | 229 (85.1) | .91 | 213 (83.9) | 204 (77.9) | .08 | .03 | |
| No | 40 (15.2) | 40 (14.9) | 41 (16.1) | 58 (22.1) | ||||
| Yes or Not clear | 184 (70.0) | 188 (69.9) | .96 | 171 (67.3) | 148 (56.5) | .01 | .001 | |
| No | 79 (30.0) | 81 (30.1) | 83 (32.7) | 114 (43.5) | ||||
| Yes or Not clear | 187 (71.1) | 192 (71.4) | .95 | 181 (71.3) | 157 (59.9) | .01 | .005 | |
| No | 76 (28.9) | 77 (28.6) | 73 (28.7) | 105 (40.1) | ||||
| Yes or Not clear | 175 (66.5) | 172 (63.9) | .53 | 153 (60.2) | 98 (37.4) | <.001 | <.001 | |
| No | 88 (33.5) | 97 (36.1) | 101 (39.8) | 164 (62.6) | ||||
| Yes or Not clear | 231 (87.8) | 238 (88.5) | .82 | 221 (87.0) | 210 (80.2) | .04 | .008 | |
| No | 32 (12.2) | 31 (11.5) | 33 (13.0) | 52 (19.8) | ||||
| Yes or Not clear | 166 (63.1) | 172 (63.9) | .84 | 158 (62.2) | 130 (49.6) | .004 | .001 | |
| No | 97 (36.9) | 97 (36.1) | 96 (37.8) | 132 (50.4) | ||||
| Yes | 92 (35.0) | 96 (35.7) | .87 | 91 (35.8) | 193 (73.7) | .001 | <.001 | |
| No or Not clear | 171 (65.0) | 173 (64.3) | 163 (64.2) | 69 (26.3) | ||||
| Yes | 80 (40.0) | 81 (39.1) | .86 | 88 (42.5) | 140 (66.7) | <.001 | <.001 | |
| No or Not clear | 119 (60.0) | 126 (60.9) | 119 (57.5) | 70 (33.3) | ||||
| Yes | 30 (47.6) | 29 (46.8) | .93 | 22 (46.8) | 36 (69.2) | .02 | .02 | |
| No or Not clear | 33 (52.4) | 33 (53.2) | 25 (53.2) | 16 (30.8) | ||||
aRTIs: respiratory tract infections.
bGTIs: gastrointestinal tract infections.
Antibiotics prescription by baseline, endpoint, control, and intervention groups.
| Antibiotics prescription | Baseline | Endpoint | Overall | |||||
| Control, n (%) | Intervention, n (%) | Control, n (%) | Intervention, n (%) | |||||
| Oral | 97 (66.0) | 122 (65.6) | .94 | 92 (60.5) | 85 (42.3) | .001 | <.001 | |
| Intravenous | 89 (53.0) | 95 (54.0) | .89 | 85 (51.2) | 71 (38.4) | .02 | .003 | |
| Any | 159 (90.3) | 176 (87.1) | .33 | 156 (89.7) | 135 (64.3) | <.001 | <.001 | |
| Oral | 34 (68.0) | 32 (64.0) | .67 | 25 (62.5) | 6 (12.8) | <.001 | <.001 | |
| Intravenous | 30 (60.0) | 34 (58.6) | .88 | 21 (60.0) | 16 (36.4) | .04 | .03 | |
| Any | 50 (96.2) | 54 (94.7) | .72 | 36 (90.0) | 22 (52.4) | <.001 | <.001 | |
| Oral | 131 (66.5) | 154 (65.3) | .79 | 117 (60.9) | 91 (36.7) | <.001 | <.001 | |
| Intravenous | 119 (54.6) | 129 (55.1) | .91 | 106 (52.7) | 87 (38.0) | .002 | <.001 | |
| Any | 209 (91.7) | 230 (88.8) | .29 | 192 (89.7) | 157 (62.3) | <.001 | <.001 | |
aRTIs: respiratory tract infections.
bGTIs: gastrointestinal tract infections.